TrialClinical and vaccine immunology : CVI2007

Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.

Jamie Hosking et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.